2024 ICD-10-CM Diagnosis Code T44.7X5
Adverse effect of beta-adrenoreceptor antagonists
- ICD-10-CM Code:
- T44.7X5
- ICD-10 Code for:
- Adverse effect of beta-adrenoreceptor antagonists
- Is Billable?
- Not Valid for Submission
- Code Navigator:
T44.7X5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of adverse effect of beta-adrenoreceptor antagonists. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding Applicable to Adverse effect of beta-adrenoreceptor antagonists
Non-specific codes like T44.7X5 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for adverse effect of beta-adrenoreceptor antagonists:
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acebutolol adverse reaction
- Adverse reaction caused by metoprolol succinate
- Adverse reaction caused by metoprolol tartrate
- Adverse reaction to nebivolol
- Atenolol adverse reaction
- Beta-adrenoceptor blocking drug adverse reaction
- Betaxolol adverse reaction
- Bisoprolol adverse reaction
- Cardioselective beta-blocker adverse reaction
- Carteolol adverse reaction
- Carvedilol adverse reaction
- Celiprolol adverse reaction
- Class II antiarrhythmic adverse reaction
- Class II antiarrhythmic adverse reaction
- Class II antiarrhythmic adverse reaction
- Class III antiarrhythmic adverse reaction
- Esmolol adverse reaction
- Metoprolol adverse reaction
- Nadolol adverse reaction
- Oxprenolol adverse reaction
- Penbutolol adverse reaction
- Pindolol adverse reaction
- Practolol adverse reaction
- Propranolol adverse reaction
- Sotalol adverse reaction
- Timolol adverse reaction
Clinical Information
Acebutolol
a cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. the drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.Alprenolol
one of the adrenergic beta-antagonists used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.Atenolol
a cardioselective beta-1 adrenergic blocker possessing properties and potency similar to propranolol, but without a negative inotropic effect.Betaxolol
a cardioselective beta-1-adrenergic antagonist with no partial agonist activity.Bisoprolol
a cardioselective beta-1 adrenergic blocker. it is effective in the management of hypertension and angina pectoris.Bupranolol
an adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.Carteolol
a beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.Celiprolol
a cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. it is used in the management of angina pectoris and hypertension.Metoprolol
a selective adrenergic beta-1 blocking agent that is commonly used to treat angina pectoris; hypertension; and cardiac arrhythmias.Nadolol
a non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. nadolol is also used for migraine disorders and for tremor.Oxprenolol
a beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.Penbutolol
a nonselective beta-blocker used as an antihypertensive and an antianginal agent.Pindolol
a moderately lipophilic beta blocker (adrenergic beta-antagonists). it is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (from martindale, the extra pharmocopoeia, 30th ed, p638)Practolol
a beta-1 adrenergic antagonist that has been used in the emergency treatment of cardiac arrythmias.Propranolol
a widely used non-cardioselective beta-adrenergic antagonist. propranolol has been used for myocardial infarction; arrhythmia; angina pectoris; hypertension; hyperthyroidism; migraine; pheochromocytoma; and anxiety but adverse effects instigate replacement by newer drugs.Sotalol
an adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.Timolol
a beta-adrenergic antagonist that is similar in action to propranolol; the levo-isomer is more active. timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. it is also used in the treatment of migraine disorders and tremor.
Coding Guidelines
When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system (T44). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Table of Drugs and Chemicals
The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Drug Reactions
Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.
What is a drug interaction?
A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:
- Two drugs, such as aspirin and blood thinners
- Drugs and food, such as statins and grapefruit
- Drugs and supplements, such as gingko and blood thinners
- Drugs and medical conditions, such as aspirin and peptic ulcers
Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.
What are side effects?
Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.
What are drug allergies?
Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.
How can I stay safe when taking medicines?
When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.